Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors.
Weixin BeiShuhui DongGuoying LiuLanfeng LinYaofei JiangNian LuWangzhong LiHu LiangYan-Qun XiangWeixiong XiaPublished in: Cancer management and research (2024)
mNPC patients who progressed from prior anti-PD1 therapy could benefit from the anti-PD1 rechallenge in combination with chemotherapy. However, further validation is needed.